| CGARX | CGGGX | CGARX / CGGGX | |
| Total Expense Ratio | 0.64 | 0.69 | 93% |
| Annual Report Gross Expense Ratio | 0.64 | 0.74 | 86% |
| Fund Existence | 4 years | 8 years | - |
| Gain YTD | 1.994 | 2.291 | 87% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 5000000 | 250 | 2,000,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 376M | 7.23B | 5% |
| Annual Yield % from dividends | 1.83 | 0.88 | 207% |
| Returns for 1 year | 11.61 | 15.47 | 75% |
| Returns for 3 years | 33.15 | 50.85 | 65% |
| Returns for 5 years | N/A | 20.36 | - |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VALSX | 30.51 | 0.19 | +0.63% |
| Value Line Select Growth Fund | |||
| MQGIX | 56.28 | 0.04 | +0.07% |
| MFS International Growth I | |||
| TSPTX | 5.37 | -0.02 | -0.37% |
| Transamerica Small Cap Growth I3 | |||
| CLXRX | 56.35 | -0.29 | -0.51% |
| Columbia Large Cap Index Inst2 | |||
| FTDZX | 177.41 | -1.68 | -0.94% |
| Franklin Biotechnology Discovery Adv | |||